AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Gene therapy in the treatment of human cancer
Authors: Gomez-Navarro, J Bilbao, G Curiel, DT
Citation: J. Gomez-navarro et al., Gene therapy in the treatment of human cancer, MOLECULAR BASIS OF HUMAN CANCER, 2002, pp. 541-565
An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression
Authors: Hemminki, A Belousova, N Zinn, KR Liu, B Wang, MH Chaudhuri, TR Rogers, BE Buchsbaum, DJ Siegal, GP Barnes, MN Gomez-Navarro, J Curiel, DT Alvarez, RD
Citation: A. Hemminki et al., An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression, MOL THER, 4(3), 2001, pp. 223-231
Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors
Authors: Garcia-Castro, J Segovia, JC Garcia-Sanchez, F Lillo, R Gomez-Navarro, J Curiel, DT Bueren, JA
Citation: J. Garcia-castro et al., Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors, MOL THER, 3(1), 2001, pp. 70-77
Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications
Authors: Casado, E Gomez-Navarro, J Yamamoto, M Adachi, Y Coolidge, CJ Arafat, WO Barker, SD Wang, MH Mahasreshti, PJ Hemminki, A Gonzalez-Baron, M Barnes, MN Pustilnik, TB Siegal, GP Alvarez, RD Curiel, DT
Citation: E. Casado et al., Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications, CLIN CANC R, 7(8), 2001, pp. 2496-2504
Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix
Authors: Huh, WK Gomez-Navarro, J Arafat, WO Xiang, JL Marameshwar, PJ Alvarez, RD Barnes, MN Curiel, DT
Citation: Wk. Huh et al., Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix, GYNECOL ONC, 83(2), 2001, pp. 370-377
Transcriptional targeting for ovarian cancer gene therapy
Authors: Casado, E Nettelbeck, DM Gomez-Navarro, J Hemminki, A Baron, MG Siegal, GP Barnes, MN Alvarez, RD Curiel, DT
Citation: E. Casado et al., Transcriptional targeting for ovarian cancer gene therapy, GYNECOL ONC, 82(2), 2001, pp. 229-237
An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites
Authors: Barker, SD Casado, E Gomez-Navarro, J Xiang, J Arafat, W Mahasreshti, P Pustilnik, TB Hemminki, A Siegal, GP Alvarez, RD Curiel, DT
Citation: Sd. Barker et al., An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites, GYNECOL ONC, 82(1), 2001, pp. 57-63
Adenoviral-mediated suicide gene therapy for ovarian cancer
Authors: Alvarez, RD Gomez-Navarro, J Wang, MH Barnes, MN Strong, TV Arani, RB Arafat, W Hughes, JV Siegal, GP Curiel, DT
Citation: Rd. Alvarez et al., Adenoviral-mediated suicide gene therapy for ovarian cancer, MOL THER, 2(5), 2000, pp. 524-530
An adenovirus encoding proapoptotic Bax induces apoptosis and enhances theradiation effect in human ovarian cancer
Authors: Arafat, WO Gomez-Navarro, J Xiang, JL Barnes, MN Mahasreshti, P Alvarez, RD Siegal, GP Badib, AO Buchsbaum, D Curiel, DT Stackhouse, MA
Citation: Wo. Arafat et al., An adenovirus encoding proapoptotic Bax induces apoptosis and enhances theradiation effect in human ovarian cancer, MOL THER, 1(6), 2000, pp. 545-554
Gene therapy for carcinoma of the breast - Pro-apoptotic gene therapy
Authors: Gomez-Navarro, J Arafat, W Xiang, JL
Citation: J. Gomez-navarro et al., Gene therapy for carcinoma of the breast - Pro-apoptotic gene therapy, BREAST CA R, 2(1), 2000, pp. 32-44
Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer
Authors: Xiang, J Gomez-Navarro, J Arafat, W Liu, B Barker, SD Alvarez, RD Siegal, GP Curiel, DT
Citation: J. Xiang et al., Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer, J GENE MED, 2(2), 2000, pp. 97-106
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): A phase I trial
Authors: Alvarez, RD Barnes, MN Gomez-Navarro, J Wang, MH Strong, TV Arafat, W Arani, RB Johnson, MR Roberts, BL Siegal, GP Curiel, DT
Citation: Rd. Alvarez et al., A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): A phase I trial, CLIN CANC R, 6(8), 2000, pp. 3081-3087
Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovariancarcinoma cells versus autologous mesothelial cells in vitro
Authors: Kelly, FJ Miller, CR Buchsbaum, DJ Gomez-Navarro, J Barnes, MN Alvarez, RD Curiel, DT
Citation: Fj. Kelly et al., Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovariancarcinoma cells versus autologous mesothelial cells in vitro, CLIN CANC R, 6(11), 2000, pp. 4323-4333
Genetically modified CD34(+) cells exert a cytotoxic bystander effect on human endothelial and cancer cells
Authors: Arafat, WO Casado, E Wang, M Alvarez, RD Siegal, GP Glorioso, JC Curiel, DT Gomez-Navarro, J
Citation: Wo. Arafat et al., Genetically modified CD34(+) cells exert a cytotoxic bystander effect on human endothelial and cancer cells, CLIN CANC R, 6(11), 2000, pp. 4442-4448
Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid
Authors: Blackwell, JL Li, H Gomez-Navarro, J Dmitriev, I Krasnykh, V Richter, CA Shaw, DR Alvarez, RD Curiel, DT Strong, TV
Citation: Jl. Blackwell et al., Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid, HUM GENE TH, 11(12), 2000, pp. 1657-1669
Genetically modified CD34(+) cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model
Authors: Gomez-Navarro, J Contreras, JL Arafat, W Jiang, XL Krisky, D Oligino, T Marconi, P Hubbard, B Glorioso, JC Curiel, DT Thomas, JM
Citation: J. Gomez-navarro et al., Genetically modified CD34(+) cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model, GENE THER, 7(1), 2000, pp. 43-52
Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFvaffinity for its target
Authors: Arafat, W Gomez-Navarro, J Xiang, JL Siegal, GP Alvarez, RD Curiel, DT
Citation: W. Arafat et al., Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFvaffinity for its target, CANC GENE T, 7(9), 2000, pp. 1250-1256
Intracellular single-chain antibodies for gene therapy
Authors: Bilbao, G Gomez-Navarro, J Kazano, K Contreras, JL Curiel, DT
Citation: G. Bilbao et al., Intracellular single-chain antibodies for gene therapy, METH MOL M, 35, 2000, pp. 121-149
An inducible recombinant adenoviral vector encoding Bax selectively induces apoptosis in ovarian cancer cells
Authors: Xiang, J Piche, A Rancourt, C Gomez-Navarro, J Siegal, GP Alvarez, RD Curiel, DT
Citation: J. Xiang et al., An inducible recombinant adenoviral vector encoding Bax selectively induces apoptosis in ovarian cancer cells, TUMOR TARG, 4(2), 1999, pp. 84-91
Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy
Authors: Rancourt, C Piche, A Gomez-Navarro, J Wang, MH Alvarez, RD Siegel, GP Fuller, GM Jones, SA Curiel, DT
Citation: C. Rancourt et al., Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy, CLIN CANC R, 5(1), 1999, pp. 43-50
Detection of coxsackie-adenovirus receptor (CAR) immunoreactivity in ovarian tumors of epithelial derivation
Authors: Khuu, H Conner, M Vanderkwaak, T Shultz, J Gomez-Navarro, J Alvarez, RD Curiel, DT Siegal, GP
Citation: H. Khuu et al., Detection of coxsackie-adenovirus receptor (CAR) immunoreactivity in ovarian tumors of epithelial derivation, APPL IMMUNO, 7(4), 1999, pp. 266-270
Gene therapy for cancer
Authors: Gomez-Navarro, J Curiel, DT Douglas, JT
Citation: J. Gomez-navarro et al., Gene therapy for cancer, EUR J CANC, 35(6), 1999, pp. 867-885
Gene therapy for cancer (Reprinted from Eur J Cancer, vol 35, pg 867-885, 1999)
Authors: Gomez-Navarro, J Curiel, DT Douglas, JT
Citation: J. Gomez-navarro et al., Gene therapy for cancer (Reprinted from Eur J Cancer, vol 35, pg 867-885, 1999), EUR J CANC, 35(14), 1999, pp. 2039-2057
An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches
Authors: Vanderkwaak, TJ Wang, MH Gomez-Navarro, J Rancourt, C Dmitriev, I Krasnykh, V Barnes, M Siegal, GP Alvarez, R Curiel, DT
Citation: Tj. Vanderkwaak et al., An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches, GYNECOL ONC, 74(2), 1999, pp. 227-234
Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation
Authors: Bilbao, G Contreras, JL Gomez-Navarro, J Eckhoff, DE Mikheeva, G Krasnykh, V Hynes, T Thomas, FT Thomas, JM Curiel, DT
Citation: G. Bilbao et al., Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation, TRANSPLANT, 67(6), 1999, pp. 775-783
Risultati: 1-25 | 26-26